News
The Vermont Department of Financial Regulation has rejected the licensing application of the Vermont Health CO-OP, finding "an extremely high risk of insolvency" and effectively barring the CO-OP from selling on the state insurance exchange this year.
Last week, Parkland Memorial Hospital in Dallas announced an agreement to pay a $1.4 million settlement to the United States Department of Justice over Medicare and Medicaid fraud allegations.
With the European and U.S. healthcare markets working to reduce spending, the global medical device market reached $331 billion in 2012, a growth rate of 3 percent from 2011, according to Kalorama Information.
The Healthy Artists project pulled together students, artists, politicians and the healthcare community to address the issue of lack of insurance in the U.S.
The cost of healthcare in 2013 for a family of four receiving health benefits through an employer-sponsored preferred provide organization (PPO) now exceeds $22,000 per year, according to the Milliman Medical Index (MMI) published this week by consulting and actuarial firm Milliman Inc.
Covered California, soon to be the nation's largest state insurance exchange, is touting the relatively low premium rates tentatively secured for individual health plans -- but HIX officials are comparing those to existing small group market rates, which isn't entirely apt.
In "Catastrophic Care: How American Health Care Killed My Father -- And How We Can Fix It," author David Goldhill channels his incredulousness over how the healthcare system operates into an open challenge to society and the healthcare industry to examine why the healthcare system is the way it is and how it can be changed. He talked to Healthcare Finance News about his book.
In the first disclosure of individual health insurance premiums by the nation's largest state, California announced on Thursday a wide array of choices for the 5.3 million people expected to qualify to purchase coverage through its online marketplace established by the Affordable Care Act.
Price transparency is a touchy subject in healthcare, and experts are divided on how much value exposing prices has for consumers and how much impact it would have on the industry.
Generic drug maker, Actavis Inc., is acquiring specialty pharmaceutical company Warner Chilcott in a stock transaction valued at $8.5 billion, creating the third largest U.S., announced the company on Monday. The deal is expected to close by the end of the year.